How many patents does
Astrazeneca have?
patents
15,860
families
1,782
granted
3,402
applications
12,458
US
2,188
EP
1,540
CN
1,067
WO
715
KR
484
JP
369
GB
54
RoW
9,443
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Astrazeneca
Top ten assignees appearing on patents
2009 - 2018
| astrazeneca | 12136 |
| amylin pharmaceuticals | 577 |
| astrazeneca uk | 455 |
| medimmune | 359 |
| array biopharma | 252 |
| bristol-myers squibb company | 235 |
| dainippon sumitomo pharma company | 217 |
| nycomed | 177 |
| bayer schering pharma | 147 |
| almirall | 106 |
2009
2018
| astrazeneca | 522 |
| cancer research technology | 44 |
| medimmune | 28 |
| astrazeneca uk | 18 |
| entasis therapeutics | 11 |
| amylin pharmaceuticals | 10 |
| ardea biosciences | 9 |
| biowa | 9 |
| kudos pharmaceuticals | 9 |
| eolas therapeutics | 7 |
Astrazeneca
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| compuestos de 2-(2,4,5-anilino sustituido)pirimidina | 112 | 2011 |
| n3 alkylated benzimidazole derivatives as mek inhibitors | 98 | 2002 |
| phenyl or pyridinyl substituted indazoles derivatives | 80 | 2008 |
| crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl)methyl)phenyl)-d-… 🛈 | 73 | 2006 |
| compounds and their use as bace inhibitors | 70 | 2010 |
| heterocyclic inhibitors of mek and methods of use thereof | 70 | 2005 |
| chemical process | 61 | 2005 |
| camsylate salt | 60 | 2012 |
| methods of reducing eosinophil levels | 58 | 2007 |
| chromenone derivatives with anti-tumour activity | 58 | 2009 |